+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market 2022-2026

  • PDF Icon

    Report

  • 120 Pages
  • June 2022
  • Region: Global
  • TechNavio
  • ID: 5606276
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the phosphoinositide 3-kinase (PI3K) inhibitors market and it is poised to grow by $ 71.29 mn during 2022-2026, accelerating at a CAGR of 5.09% during the forecast period. Our report on the phosphoinositide 3-kinase (PI3K) inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by recent approvals, strategic alliances, and special drug designations.

The phosphoinositide 3-kinase (PI3K) inhibitors market analysis includes the application segment and geographic landscape.

The publisher's phosphoinositide 3-kinase (PI3K) inhibitors market is segmented as below:

By Application

  • CLL
  • FL
  • Other indications

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the expansion of research indications as one of the prime reasons driving the phosphoinositide 3-kinase (PI3K) inhibitors market growth during the next few years. Also, reimbursement programs and growing awareness about cancer will lead to sizable demand in the market.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on phosphoinositide 3-kinase (PI3K) inhibitors market covers the following areas:
  • Phosphoinositide 3-kinase (PI3K) inhibitors market sizing
  • Phosphoinositide 3-kinase (PI3K) inhibitors market forecast
  • Phosphoinositide 3-kinase (PI3K) inhibitors market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading phosphoinositide 3-kinase (PI3K) inhibitors market vendors that include Bayer AG, Celon Pharma SA, Curis Inc., Exelixis Inc., Gilead Sciences Inc., Merck KGaA, Molecular Depot LLC., Novartis AG, Secura Bio Inc., and TG Therapeutics Inc. Also, the phosphoinositide 3-kinase (PI3K) inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.

The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing
  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis
  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application
  • 5.1 Market segments
  • Exhibit 24: Chart on Application - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
  • 5.2 Comparison by Application
  • Exhibit 26: Chart on Comparison by Application
  • Exhibit 27: Data Table on Comparison by Application
  • 5.3 CLL - Market size and forecast 2021-2026
  • Exhibit 28: Chart on CLL - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on CLL - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on CLL - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on CLL - Year-over-year growth 2021-2026 (%)
  • 5.4 FL - Market size and forecast 2021-2026
  • Exhibit 32: Chart on FL - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on FL - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on FL - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on FL - Year-over-year growth 2021-2026 (%)
  • 5.5 Other indications - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Other indications - Market size and forecast 2021-2026 ($ million)
  • Exhibit 37: Data Table on Other indications - Market size and forecast 2021-2026 ($ million)
  • Exhibit 38: Chart on Other indications - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Other indications - Year-over-year growth 2021-2026 (%)
  • 5.6 Market opportunity by Application
  • Exhibit 40: Market opportunity by Application ($ million)

6 Customer Landscape
  • 6.1 Customer landscape overview
  • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape
  • 7.1 Geographic segmentation
  • Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 44: Chart on Geographic comparison
  • Exhibit 45: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Germany - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.9 China - Market size and forecast 2021-2026
  • Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.10 UK - Market size and forecast 2021-2026
  • Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.11 Canada - Market size and forecast 2021-2026
  • Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends
  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape
  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 85: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 86: Impact of key risks on business

10 Vendor Analysis
  • 10.1 Vendors covered
  • Exhibit 87: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 88: Matrix on vendor position and classification
  • 10.3 Bayer AG
  • Exhibit 89: Bayer AG - Overview
  • Exhibit 90: Bayer AG - Business segments
  • Exhibit 91: Bayer AG - Key offerings
  • Exhibit 92: Bayer AG - Segment focus
  • 10.4 Celon Pharma SA
  • Exhibit 93: Celon Pharma SA - Overview
  • Exhibit 94: Celon Pharma SA - Business segments
  • Exhibit 95: Celon Pharma SA - Key offerings
  • Exhibit 96: Celon Pharma SA - Segment focus
  • 10.5 Curis Inc.
  • Exhibit 97: Curis Inc. - Overview
  • Exhibit 98: Curis Inc. - Product / Service
  • Exhibit 99: Curis Inc. - Key offerings
  • 10.6 Exelixis Inc.
  • Exhibit 100: Exelixis Inc. - Overview
  • Exhibit 101: Exelixis Inc. - Product / Service
  • Exhibit 102: Exelixis Inc. - Key offerings
  • 10.7 Gilead Sciences Inc.
  • Exhibit 103: Gilead Sciences Inc. - Overview
  • Exhibit 104: Gilead Sciences Inc. - Product / Service
  • Exhibit 105: Gilead Sciences Inc. - Key news
  • Exhibit 106: Gilead Sciences Inc. - Key offerings
  • 10.8 Merck KGaA
  • Exhibit 107: Merck KGaA - Overview
  • Exhibit 108: Merck KGaA - Business segments
  • Exhibit 109: Merck KGaA - Key news
  • Exhibit 110: Merck KGaA - Key offerings
  • Exhibit 111: Merck KGaA - Segment focus
  • 10.9 Molecular Depot LLC.
  • Exhibit 112: Molecular Depot LLC. - Overview
  • Exhibit 113: Molecular Depot LLC. - Product / Service
  • Exhibit 114: Molecular Depot LLC. - Key offerings
  • 10.10 Novartis AG
  • Exhibit 115: Novartis AG - Overview
  • Exhibit 116: Novartis AG - Business segments
  • Exhibit 117: Novartis AG - Key offerings
  • Exhibit 118: Novartis AG - Segment focus
  • 10.11 Secura Bio Inc.
  • Exhibit 119: Secura Bio Inc. - Overview
  • Exhibit 120: Secura Bio Inc. - Product / Service
  • Exhibit 121: Secura Bio Inc. - Key offerings
  • 10.12 TG Therapeutics Inc.
  • Exhibit 122: TG Therapeutics Inc. - Overview
  • Exhibit 123: TG Therapeutics Inc. - Product / Service
  • Exhibit 124: TG Therapeutics Inc. - Key offerings

11 Appendix
  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 125: Inclusions checklist
  • Exhibit 126: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 127: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 128: Research methodology
  • Exhibit 129: Validation techniques employed for market sizing
  • Exhibit 130: Information sources
  • 11.5 List of abbreviations
  • Exhibit 131: List of abbreviations

Exhibits:
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between 2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Application - Market share 2021-2026 (%)
Exhibits 25: Data Table on Application - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Application
Exhibits 27: Data Table on Comparison by Application
Exhibits 28: Chart on CLL - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on CLL - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on CLL - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on CLL - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on FL - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on FL - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on FL - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on FL - Year-over-year growth 2021-2026 (%)
Exhibits 36: Chart on Other indications - Market size and forecast 2021-2026 ($ million)
Exhibits 37: Data Table on Other indications - Market size and forecast 2021-2026 ($ million)
Exhibits 38: Chart on Other indications - Year-over-year growth 2021-2026 (%)
Exhibits 39: Data Table on Other indications - Year-over-year growth 2021-2026 (%)
Exhibits 40: Market opportunity by Application ($ million)
Exhibits 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 44: Chart on Geographic comparison
Exhibits 45: Data Table on Geographic comparison
Exhibits 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 82: Market opportunity By Geographical Landscape ($ million)
Exhibits 83: Impact of drivers and challenges in 2021 and 2026
Exhibits 84: Overview on Criticality of inputs and Factors of differentiation
Exhibits 85: Overview on factors of disruption
Exhibits 86: Impact of key risks on business
Exhibits 87: Vendors covered
Exhibits 88: Matrix on vendor position and classification
Exhibits 89: Bayer AG - Overview
Exhibits 90: Bayer AG - Business segments
Exhibits 91: Bayer AG - Key offerings
Exhibits 92: Bayer AG - Segment focus
Exhibits 93: Celon Pharma SA - Overview
Exhibits 94: Celon Pharma SA - Business segments
Exhibits 95: Celon Pharma SA - Key offerings
Exhibits 96: Celon Pharma SA - Segment focus
Exhibits 97: Curis Inc. - Overview
Exhibits 98: Curis Inc. - Product / Service
Exhibits 99: Curis Inc. - Key offerings
Exhibits 100: Exelixis Inc. - Overview
Exhibits 101: Exelixis Inc. - Product / Service
Exhibits 102: Exelixis Inc. - Key offerings
Exhibits 103: Gilead Sciences Inc. - Overview
Exhibits 104: Gilead Sciences Inc. - Product / Service
Exhibits 105: Gilead Sciences Inc. - Key news
Exhibits 106: Gilead Sciences Inc. - Key offerings
Exhibits 107: Merck KGaA - Overview
Exhibits 108: Merck KGaA - Business segments
Exhibits 109: Merck KGaA - Key news
Exhibits 110: Merck KGaA - Key offerings
Exhibits 111: Merck KGaA - Segment focus
Exhibits 112: Molecular Depot LLC. - Overview
Exhibits 113: Molecular Depot LLC. - Product / Service
Exhibits 114: Molecular Depot LLC. - Key offerings
Exhibits 115: Novartis AG - Overview
Exhibits 116: Novartis AG - Business segments
Exhibits 117: Novartis AG - Key offerings
Exhibits 118: Novartis AG - Segment focus
Exhibits 119: Secura Bio Inc. - Overview
Exhibits 120: Secura Bio Inc. - Product / Service
Exhibits 121: Secura Bio Inc. - Key offerings
Exhibits 122: TG Therapeutics Inc. - Overview
Exhibits 123: TG Therapeutics Inc. - Product / Service
Exhibits 124: TG Therapeutics Inc. - Key offerings
Exhibits 125: Inclusions checklist
Exhibits 126: Exclusions checklist
Exhibits 127: Currency conversion rates for US$
Exhibits 128: Research methodology
Exhibits 129: Validation techniques employed for market sizing
Exhibits 130: Information sources
Exhibits 131: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global phosphoinositide 3-kinase (PI3K) inhibitors market: Bayer AG, Celon Pharma SA, Curis Inc., Exelixis Inc., Gilead Sciences Inc., Merck KGaA, Molecular Depot LLC., Novartis AG, Secura Bio Inc., and TG Therapeutics Inc.

Commenting on the report, an analyst from the publisher said: "The latest trend gaining momentum in the market is expansion of research indications."

According to the report, one of the major drivers for this market is the recent approvals.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry.

The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.


Companies Mentioned

A selection of companies mentioned in this report includes:

  • Bayer AG
  • Celon Pharma SA
  • Curis Inc.
  • Exelixis Inc.
  • Gilead Sciences Inc.
  • Merck KGaA
  • Molecular Depot LLC.
  • Novartis AG
  • Secura Bio Inc.
  • TG Therapeutics Inc.